IDEAYA Announces First Patient Dosed in Phase 1 Clinical Trial for IDE161 as Potential First-in-Class PARG Inhibitor Targeting HRD Solid Tumors

April 19, 2023

Biotechnology

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 18, 2024
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

April 16, 2024
SciSparc to Acquire AutoMax

April 11, 2024
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

April 11, 2024